Avantor announces J.T. Baker Cell Lysis Solution and J.T. Baker Endonuclease (NYSE:AVTR)
2024-07-01
Avantor (NYSE:AVTR) on Monday announced the launch of two products that optimize the gene therapy harvest process – J.T. Baker Cell Lysis Solution and J.T. Baker Endonuclease. The company said that pairing J.T. Baker Cell Lysis Solution with J.T. Baker Endonuclease can further reduce the number of steps at harvest.Continue Reading